RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Gland Pharma Stock

Gland Pharma EBIT 2025

Gland Pharma EBIT

10.48 B INR

Ticker

GLAND.NS

ISIN

INE068V01023

In 2025, Gland Pharma's EBIT was 10.48 B INR, a 5.99% increase from the 9.89 B INR EBIT recorded in the previous year.

The Gland Pharma EBIT history

YEAREBIT (undefined INR)
2027e15.44
2026e13.42
2025e10.48
20249.89
20238.84
202214
202112.03
20208.61
20196.24
20184.99

Gland Pharma Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Gland Pharma, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Gland Pharma from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Gland Pharma’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Gland Pharma. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Gland Pharma’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Gland Pharma’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Gland Pharma’s growth potential.

Gland Pharma Revenue, EBIT and net profit per share

DateGland Pharma RevenueGland Pharma EBITGland Pharma Net Income
2027e78.71 B INR15.44 B INR12.73 B INR
2026e70.9 B INR13.42 B INR10.83 B INR
2025e62.99 B INR10.48 B INR8.26 B INR
202456.65 B INR9.89 B INR7.72 B INR
202336.25 B INR8.84 B INR7.81 B INR
202244.01 B INR14 B INR12.12 B INR
202134.63 B INR12.03 B INR9.97 B INR
202026.33 B INR8.61 B INR7.73 B INR
201920.44 B INR6.24 B INR4.52 B INR
201816.23 B INR4.99 B INR3.21 B INR

Gland Pharma stock margins

The Gland Pharma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Gland Pharma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Gland Pharma.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Gland Pharma's sales revenue. A higher gross margin percentage indicates that the Gland Pharma retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Gland Pharma's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Gland Pharma's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Gland Pharma's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Gland Pharma. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Gland Pharma's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Gland Pharma Margin History

Gland Pharma Gross marginGland Pharma Profit marginGland Pharma EBIT marginGland Pharma Profit margin
2027e60.61 %19.62 %16.18 %
2026e60.61 %18.93 %15.28 %
2025e60.61 %16.63 %13.11 %
202460.61 %17.45 %13.64 %
202352.18 %24.4 %21.55 %
202251.16 %31.81 %27.53 %
202155.58 %34.75 %28.79 %
202056.85 %32.69 %29.35 %
201956.79 %30.54 %22.11 %
201857.83 %30.77 %19.79 %

Gland Pharma Aktienanalyse

What does Gland Pharma do?

Gland Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Gland Pharma's EBIT

Gland Pharma's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Gland Pharma's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Gland Pharma's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Gland Pharma’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Gland Pharma stock

How much did Gland Pharma achieve in EBIT for the current year?

In the current year, Gland Pharma has achieved an EBIT of 10.48 B INR.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Gland Pharma.

How has the EBIT of Gland Pharma developed in recent years?

The EBIT of Gland Pharma has increased by 5.988% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Gland Pharma?

The EBIT of Gland Pharma is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Gland Pharma pay?

Over the past 12 months, Gland Pharma paid a dividend of 20 INR . This corresponds to a dividend yield of about 1.32 %. For the coming 12 months, Gland Pharma is expected to pay a dividend of 20 INR.

What is the dividend yield of Gland Pharma?

The current dividend yield of Gland Pharma is 1.32 %.

When does Gland Pharma pay dividends?

Gland Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gland Pharma?

Gland Pharma paid dividends every year for the past 0 years.

What is the dividend of Gland Pharma?

For the upcoming 12 months, dividends amounting to 20 INR are expected. This corresponds to a dividend yield of 1.32 %.

In which sector is Gland Pharma located?

Gland Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gland Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gland Pharma from 9/29/2024 amounting to 20 INR, you needed to have the stock in your portfolio before the ex-date on 8/16/2024.

When did Gland Pharma pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Gland Pharma in the year 2024?

In the year 2024, Gland Pharma distributed 0 INR as dividends.

In which currency does Gland Pharma pay out the dividend?

The dividends of Gland Pharma are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gland Pharma

Our stock analysis for Gland Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gland Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.